Fortress Biotech (FBIO) Notes Payables (2012 - 2025)

Fortress Biotech's Notes Payables history runs 13 years deep, the most recent figure standing at $625000.0 for Q4 2024.

• In Q4 2024, Notes Payables fell 79.17% year-over-year to $625000.0; the TTM figure through Dec 2024 stood at $625000.0 (down 79.17% YoY), while the FY2024 annual figure was $625000.0, down 79.17% from the prior year.
• Notes Payables for Q4 2024 stood at $625000.0, down from $1.2 million in the prior quarter.
• The five-year high for Notes Payables was $21.8 million in Q2 2020, with the low at $13000.0 in Q1 2020.
• The 5-year median for Notes Payables is $3.0 million (2023), against an average of $4.9 million.
• The sharpest annual moves came in 2020 and 2021: Notes Payables slumped 99.86% in 2020, then jumped 41923.08% in 2021.
• Fortress Biotech's Notes Payables stood at $4.5 million in 2020, then fell by 0.27% to $4.5 million in 2021, then sank by 34.63% to $2.9 million in 2022, then gained by 1.76% to $3.0 million in 2023, then tumbled by 79.17% to $625000.0 in 2024.
• Business Quant data shows FBIO's Notes Payables at $625000.0 in Q4 2024, $1.2 million in Q3 2024, and $3.0 million in Q2 2024.